ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 558

Fli-1 Regulates Immune Cell Infiltration Through Affecting Local Chemokine Expression and IL-6 Expression In The Kidney Of Lupus Prone Mice

Shuzo Sato1, Sarah Williams2, Eva Karam3 and Xian Zhang4, 1Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC, 2Ralph H. Johnson VA Medical Center, Charleston, SC, 3Medicine, Medical University of South Carolina, Charleston, SC, 4Medicine, Medical University of South Carolina and Ralph H. Johnson VA Medical Center, Charleston, SC

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: chemokines, IL-6, lupus nephritis and mouse model

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: Fli-1 expression level, a member of the Ets family of transcription factors, is a mitigating factor in the development of nephritis in murine models of systemic lupus erythematosus. We have reported that reduced expression of Fli-1 in MRL/lpr mice, a murine model of lupus, resulted in significantly prolonged survival and reduced glomerulonephritis. Inflammatory cell infiltration into the kidney plays a critical role in lupus nephritis progression. In kidney, Fli-1 is mainly expressed in endothelial cells in the interstitial capillaries and glomerulus. The role of Fli-1 regarding immune cell infiltration into the kidney is still unclear. We hypothesized that reduced Fli-1 expression affects local chemokine expression, cytokine production and influences immune cell infiltration into the kidney. To investigate this hypothesis, we performed following experiments.

Methods: We generated MRL/lpr transgenic mice expressing green fluorescent protein (GFP), and isolated spleen cells from these mice (6 to 8 months old). One million cells were injected into 9 Fli-1 heterozygous (+/-) and 13 wild-type (WT) MRL/lpr mice (4 to 8-month-old). Mice were sacrificed 18 hours after injection, after that kidneys were removed and frozen sections were made. Inflammatory cells with GFP were counted by immunofluorescence studies. The expression of chemokines (CCL2, CCL3, CCL4, and CCL5) and IL-6 in the recipient kidney was analyzed by real-time PCR. To investigate whether the Fli-1 disruption actually reduces cytokine production in vitro, we transfected Fli-1 specific siRNA to the MS1 cells (murine endothelial cell line) and analyzed the supernatant IL-6 concentration after LPS stimulation. In addition, whether Fli-1 directly regulates IL-6 expression by binding IL-6 promoter region, we performed chromatin immunoprecipitation (ChIP) assay using anti-Fli-1 antibody in MS1 cells. Isolated ChIP DNA was amplified by real-time PCR using IL-6 promoter primers.

Results: The infiltrated GFP positive inflammatory cells were significantly decreased in kidneys of Fli-1+/- MRL/lpr mice. The number of infiltrated T cells, B cells and macrophages were also significantly decreased. The relative mRNA expression of chemokines (CCL2, 3 and 4) and IL-6 in the kidney (WT vs Fli-1+/-) showed significantly lower in Fli-1+/- MRL/lpr mice. CCL5 expression was also showed lower trends (P=0.079). Fli-1 disruption of MS1 cells using siRNA showed reduced production of IL-6 after LPS stimulation. Furthermore, ChIP assay using IL-6 promoter primers indicated that Fli-1 directly binds to IL-6 promoter regions in murine endothelial cells.

Conclusion: Fli-1 regulates lupus nephritis development by modulating expression of inflammatory chemokines, IL-6 and immune cell infiltration into the kidney.


Disclosure:

S. Sato,
None;

S. Williams,
None;

E. Karam,
None;

X. Zhang,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fli-1-regulates-immune-cell-infiltration-through-affecting-local-chemokine-expression-and-il-6-expression-in-the-kidney-of-lupus-prone-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology